← Eichor
Condition: Clostridioides Difficile Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Clostridioides Difficile Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

FMT in Initial CDI
NA · 1 location(s) · Turku University Hospital · NCT05257538
Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections
Phase N/A · 1 location(s) · The Second Hospital of Nanjing Medical University · NCT03895593
FMT Capsules for rCDI
Phase 3 · 1 location(s) · Helsinki University Central Hospital · NCT07458984
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
NA · 1 location(s) · Krunal Patel · NCT03562741
Fecal Microbiota Transplant National Registry
Phase N/A · 53 location(s) · American Gastroenterological Association · NCT03325855
An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Pat
Phase 1 · 1 location(s) · University of Minnesota · NCT06692179
Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection
Phase 1 · 1 location(s) · University of Minnesota · NCT06370884
LMN-201 for Prevention of C. Difficile Infection Recurrence
Phase 2/Phase 3 · 16 location(s) · Lumen Bioscience, Inc. · NCT05330182
Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population
Phase 1 · 2 location(s) · University of Alberta · NCT07401680
Lifestyle and Recurrent Clostridioides Difficile Infection (CDI)
NA · 1 location(s) · University of Michigan · NCT07613645
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
Phase 2 · 2 location(s) · University of Virginia · NCT04305769
Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile
NA · 1 location(s) · Brigham and Women's Hospital · NCT05389904
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Phase 2 · 116 location(s) · AstraZeneca · NCT07285213
Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients
Phase 2/Phase 3 · 1 location(s) · Riverside University Health System Medical Center · NCT07221370
Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance
Phase N/A · 1 location(s) · Fondation Hôpital Saint-Joseph · NCT06030245
Study on Clostridium Difficile Infection in Infants
Phase N/A · 1 location(s) · First People's Hospital of Hangzhou · NCT06703918
Clostridioides Difficile: Understanding Responses and Treatment Effects
Phase N/A · 1 location(s) · Umeå University · NCT07374094
Fecal Microbiota Transplantation for C Diff Infection
NA · 1 location(s) · Englewood Hospital and Medical Center · NCT01905709
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
Phase N/A · 4 location(s) · Bactolife A/S · NCT07250724
Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05739825
Study of Clostridioides Difficile in Infants
Phase N/A · 1 location(s) · Westlake University · NCT06788769
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach
Phase 1/Phase 2 · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06071312
Safety and Efficacy of Fecal Microbiota Transplantation
NA · 1 location(s) · Chinese University of Hong Kong · NCT04014413
Safety Registry of a Fecal Microbiota Transplant Cohort
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06311006
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Phase 3 · 215 location(s) · Vedanta Biosciences, Inc. · NCT06237452
Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in Hi
Phase 1/Phase 2 · 10 location(s) · Hospices Civils de Lyon · NCT06306014
Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06228352
Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain in Nephrology and Transplantati
NA · 1 location(s) · Medical University of Silesia · NCT06859437
Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence
Phase 3 · 8 location(s) · Benoit Guery · NCT05266807
MTC Versus FMT in for RCDI
Phase 1 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT05911997
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.